The recent survey from GlobalData- The State of the Biopharmaceutical Industry 2024, went on to reveal that 44% of the healthcare industry professionals that were surveyed globally happen to be optimistic or very optimistic when it comes to the recovery of biotech funding in the coming 12 months. This optimism comes after a downturn in […]
Related Articles
This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here